A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
ROCKET-Ignite
A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD)
2 other identifiers
interventional
769
21 countries
202
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started May 2022
Typical duration for phase_3
202 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2022
CompletedStudy Start
First participant enrolled
May 31, 2022
CompletedFirst Posted
Study publicly available on registry
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2025
CompletedNovember 24, 2025
November 1, 2025
2.5 years
May 24, 2022
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Achievement of a Validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD) score of 0 or 1 with ≥2 point reduction from baseline at Week 24
Baseline, Week 24
Achievement of ≥75% reduction from baseline in Eczema Area and Severity Index (EASI) score at Week 24
Baseline, Week 24
Secondary Outcomes (28)
Achievement of ≥75% reduction from baseline in EASI score at Week 16
Baseline, Week 16
Achievement of a vIGA-AD score of 0 or 1 from baseline at Week 16
Baseline, Week 16
Achievement of a ≥ 4-point reduction from baseline in weekly average of daily worst pruritus numerical rating scale (NRS) score at Week 16 in subjects with baseline weekly average of daily worst pruritus NRS score ≥ 4
Baseline, Week 16
Achievement of a ≥ 4-point reduction from baseline in weekly average of daily worst pruritus NRS score at Week 24 in subjects with baseline weekly average of daily worst pruritus NRS score ≥ 4
Baseline, Week 24
Achievement of ≥90% reduction from baseline in EASI score at Week 24
Baseline, Week 24
- +23 more secondary outcomes
Study Arms (3)
Arm A
EXPERIMENTALRocatinlimab Dose 1 every 4 weeks (Q4W) + loading dose at Week 2
Arm B
EXPERIMENTALRocatinlimab Dose 2 Q4W + loading dose at Week 2
Arm C
PLACEBO COMPARATORPlacebo Q4W+ loading dose at Week 2
Interventions
Participants will receive Rocatinlimab subcutaneously.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years with a diagnosis of AD according to the AAD Consensus Criteria (2014) present for at least 12 months
- History of inadequate response to TCS (Topical Corticosteroid) of medium to higher potency (with or without topical calcineurin inhibitors \[TCI\]).
- EASI score ≥16
- vIGA-AD score ≥3
- ≥10% body surface area (BSA) of AD involvement
- Worst pruritus numerical rating scale ≥ 4
You may not qualify if:
- Treatment with a biological product within 12 weeks or 5 half-lives, whichever is longer, prior to Day 1
- Treatment with any of the following medications or therapies within 4 weeks or 5 half-lives, whichever is longer, prior to Day 1:
- Systemic corticosteroids
- Systemic immunosuppressants
- Phototherapy
- Janus kinase inhibitors
- Treatment with any of the following medications or therapies within 1 week, prior to Day 1:
- TCS of any potency
- TCI
- Topical phosphodiesterase type 4 inhibitors
- Other topical immunosuppressive agents
- Combination topical agents including TCS of any potency, TCI, PDE4 inhibitors, or other topical immunosuppressive agents
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amgenlead
Study Sites (202)
Cahaba Dermatology and Skin Health Center
Birmingham, Alabama, 35244, United States
Alliance Dermatology and Mohs Center
Phoenix, Arizona, 85032, United States
Anaheim Clinical Trials
Anaheim, California, 92801, United States
First OC Dermatology
Fountain Valley, California, 92708, United States
Kaiser Permanente - Glendale Medical Center
Glendale, California, 91203, United States
Long Beach Research Institute
Long Beach, California, 90805, United States
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, 90027, United States
Dermatology Research Associates
Los Angeles, California, 90045, United States
Cura Clinical Research
Sherman Oaks, California, 91403, United States
IMMUNOe Research Centers
Centennial, Colorado, 80112, United States
Skin Care Research Incorporated
Boca Raton, Florida, 33486, United States
Palm Beach Dermatology Group
Delray Beach, Florida, 33484, United States
Global Research Associates
Homestead, Florida, 33030, United States
Healthy Life Research
Miami, Florida, 33175, United States
Savin Medical Group LLC
Miami Lakes, Florida, 33014, United States
Kirsch Dermatology LLC
Naples, Florida, 34102, United States
Pure Skin Dermatology and Aesthetics
Orlando, Florida, 32819, United States
Industrial Medicine Associates Ima Clinical Research Inc
St. Petersburg, Florida, 33709, United States
Genesis Clinical Research LLC
Tampa, Florida, 33606, United States
Treasure Valley Medical Research
Boise, Idaho, 83706, United States
DeNova Research
Chicago, Illinois, 60611, United States
Dundee Dermatology
West Dundee, Illinois, 60118, United States
The Indiana Clinical Trials Center PC
Plainfield, Indiana, 46168, United States
Institute for Asthma and Allergy
Chevy Chase, Maryland, 20815, United States
Continental Clinical Solutions, LLC
Towson, Maryland, 21204, United States
Henry Ford Health System
Detroit, Michigan, 48202, United States
Onyx Clinical Research
Flint, Michigan, 48532, United States
Dermatology and Skin Cancer Center of Lees Summit
Lee's Summit, Missouri, 64064, United States
Jubilee Clinical Research Inc
Las Vegas, Nevada, 89106, United States
Allcutis Research, Llc - Portsmouth
Portsmouth, New Hampshire, 03801, United States
Continental Clinical Solutions - Cherry Hill
Cherry Hill, New Jersey, 08034, United States
Industrial Medicine Associates Ima Clinical Research Inc
Hartsdale, New York, 10530, United States
Sadick Research Group
New York, New York, 10075, United States
Dermatology Specialists of Charlotte
Charlotte, North Carolina, 28277, United States
Onsite Clinical Solutions
Charlotte, North Carolina, 28277, United States
Wilmington Dermatology Center
Wilmington, North Carolina, 28405, United States
The Skin Surgery Center for Clinical Research
Winston-Salem, North Carolina, 27103, United States
Optima Research
Boardman, Ohio, 44512, United States
ClinOhio Research Services
Columbus, Ohio, 43213, United States
Unity Clinical Research
Oklahoma City, Oklahoma, 73118, United States
Dermatology Research Center of Oklahoma, PLLC
Tulsa, Oklahoma, 74132, United States
Essential Medical Research LLC
Tulsa, Oklahoma, 74137, United States
Oregon Health and Science University
Portland, Oregon, 97239, United States
DermDox Dermatology, LLC
Sugarloaf, Pennsylvania, 18249, United States
Cumberland Skin Center
Hermitage, Tennessee, 37076, United States
Dermatology Treatment and Research Center PA
Dallas, Texas, 75230, United States
The Woodlands Dermatology Associates
The Woodlands, Texas, 77380, United States
Education and Research Foundation Inc
Lynchburg, Virginia, 24501, United States
Frontier Derm Partners
Mill Creek, Washington, 98012, United States
West Virginia Research Institute
Morgantown, West Virginia, 26505, United States
Cinme - Centro de Investigaciones Metabolicas
CABA, Buenos Aires, C1027AAP, Argentina
Fundacion Respirar
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1426ABP, Argentina
Hospital Universitario Austral
Derqui, Pilar, Buenos Aires, B1629ODT, Argentina
Centro Dermatológico Schejtman
San Miguel, Buenos Aires, 1663, Argentina
InAER - Investigaciones en Alergia y Enfermedades Respiratorias
Buenos Aires, Distrito Federal, 1425, Argentina
Instituto de Neumonologia y Dermatologia
Buenos Aires, Distrito Federal, 1425, Argentina
Conexa Investigacion Clinica SA
CABA, Distrito Federal, C1012AAY, Argentina
Fundacion Estudios Clinicos
Rosario, Santa Fe Province, 2000, Argentina
Instituto de Diagnostico Abc American British Cowdray
Rosario, Santa Fe Province, 2000, Argentina
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Hospital Ernesto Dornelles
Porto Alegre, Rio Grande do Sul, 90160-093, Brazil
Upeclin-Pesq Clin FacMed Botucatu
Botucatu, São Paulo, 18618-686, Brazil
Hosp e Maternidade Dr Christovao da Gama
Santo André, São Paulo, 09030-010, Brazil
Fundacao Abc - Centro Univ Fmabc
Santo André, São Paulo, 09060-870, Brazil
Consultoria Medica e Pesquisa Clinica Cmpc
Sorocaba, São Paulo, 18040-425, Brazil
IBPClin Instituto Brasil de Pesquisa Clinica
Rio de Janeiro, 20241-180, Brazil
Alergoalfa Nucleo Diagnostico Tratamento e Pesquisa Clinica em Alergia
São Paulo, 06454-010, Brazil
Alberta Derma Surgery Centre
Edmonton, Alberta, T6G 1C3, Canada
Vida Clinical Research
Edmonton, Alberta, T6H 4J8, Canada
CCA Medical Research Corporation
Ajax, Ontario, L1S 7K8, Canada
SimcoDerm Medical and Surgical Dermatology Centre
Barrie, Ontario, L4M 7G1, Canada
LEADER Research
Hamilton, Ontario, L8L 3C3, Canada
DermEdge Research Incorporated
Mississauga, Ontario, L4Y 4C5, Canada
Canadian Dermatology Centre
North York, Ontario, M3B 0A7, Canada
Gordon Sussman Clinical Research Incorporated
North York, Ontario, M3B 3S6, Canada
Oak Ridges Aesthetics Centre
Richmond Hill, Ontario, L4E 4L6, Canada
Innovaderm Research Inc
Montreal, Quebec, H2X 2V1, Canada
Recherche Clinique Sigma Incorporated
Québec, Quebec, G1G 3Y8, Canada
Skinsense Medical Research
Saskatoon, Saskatchewan, S7K 2C1, Canada
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050, China
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 350000, China
The First Affiliated Hospital ,Sun-Yat Sen University
Guangzhou, Guangdong, 510080, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, 510091, China
Sun Yat-sen Memorial Hospital Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
The First Hospital Of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
Nanyang First Peoples Hospital
Nanyang, Henan, 473002, China
Sanmenxia Central Hospital
Sanmenxia, Henan, 472099, China
Union Hospital Tongji Medical College Huazhong University of science and Technology
Wuhan, Hubei, 430022, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
Jiangyin Hospital of Traditional Chinese Medicine
Jiangyin, Jiangsu, 214400, China
Wuxi Peoples Hospital
Wuxi, Jiangsu, 241023, China
Dermatology Hospital of Jiangxi Province
Nanchang, Jiangxi, 330000, China
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
The First Hospital of China Medical University
Shenyang, Liaoning, 110001, China
Chengdu Second Peoples Hospital
Chengdu, Sichuan, 610021, China
the First Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
Zhejiang Provincial Peoples Hospital
Hangzhou, Zhejiang, 310004, China
Affiliated Hangzhou First Peoples Hospital,Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310020, China
Taizhou Central Hospital
Taizhou, Zhejiang, 318000, China
Peking University Peoples Hospital
Beijing, 100044, China
Shanghai Skin Disease Hospital
Shanghai, 200443, China
Special Hospital for Medical Rehabilitation Naftalan
Ivanić-Grad, 10310, Croatia
Sestre milosrdnice University Hospital Center
Zagreb, 10000, Croatia
University Hospital Centre Zagreb
Zagreb, 10000, Croatia
Dermamedica, sro
Náchod, 547 01, Czechia
CCR Ostrava sro
Ostrava, 702 00, Czechia
Pratia Pardubice as
Pardubice, 530 02, Czechia
Clintrial sro
Prague, 100 00, Czechia
Pratia Prague sro
Prague, 130 00, Czechia
Fakultni nemocnice Bulovka
Prague, 180 81, Czechia
Krajska zdravotni as - Masarykova nemocnice Usti nad Labem oz
Ústí nad Labem, 401 13, Czechia
Charite - Universitaetsmedizin Berlin, Campus Mitte
Berlin, 10117, Germany
Dermatologische Gemeinschaftspraxis-Mahlow
Blankenfelde-Mahlow, 15831, Germany
Hautarztpraxis Dr Niesmann und Dr Othlinghaus
Bochum, 44793, Germany
Rosenpark Research GmbH
Darmstadt, 64283, Germany
Universitaetsklinikum Dresden
Dresden, 01307, Germany
Heinrich-Heine-Universitaet Duesseldorf - Universitaetsklinikum Duesseldorf
Düsseldorf, 40225, Germany
Universitaetsklinikum Essen
Essen, 45174, Germany
Institute for Health Services Research in Dermatology and Nursing
Hamburg, 20246, Germany
Universitaetsklinikum Heidelberg
Heidelberg, 69120, Germany
Hautarztpraxis Dres Leitz und Kollegen
Stuttgart, 70178, Germany
Universitaetsklinikum Tuebingen
Tübingen, 72076, Germany
CentroDerm GmbH
Wuppertal, 42287, Germany
Athens Naval Hospital
Athens, 11521, Greece
Thoracic General Hospital Of Athens Sotiria
Athens, 11527, Greece
University General Hospital Attikon
Athens, 12462, Greece
Andreas Syngros Hospital Of Venereal And Dermatological Diseases
Athens, 16121, Greece
University General Hospital of Ioannina
Ioannina, 45500, Greece
General University Hospital of Larissa
Larissa, 41110, Greece
Papageorgiou General Hospital
Thessaloniki, 56403, Greece
Medmare Bt
Veszprém, 8200, Hungary
Universita degli Studi Gabriele D Annunzio di Chieti e Pescara
Chieti, 66100, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia
Perugia, 06156, Italy
Azienda Ospedaliera Policlinico Umberto I
Roma, 00161, Italy
Azienda Ospedaliera Citta della Salute e della Scienza di Torino
Torino, 10126, Italy
Aichi Medical University Hospital
Nagakute-shi, Aichi-ken, 480-1195, Japan
Japan Community Healthcare Organization Chukyo Hospital
Nagoya, Aichi-ken, 457-8510, Japan
Central Clinic
Nagoya, Aichi-ken, 464-0821, Japan
Nagoya City University Hospital
Nagoya, Aichi-ken, 467-8602, Japan
Fukuoka University Hospital
Fukuoka, Fukuoka, 814-0180, Japan
Matsuo Clinic
Fukuoka, Fukuoka, 819-0373, Japan
Fukushima Medical University Hospital
Fukushima, Fukushima, 960-1295, Japan
Asahikawa City Hospital
Asahikawa-shi, Hokkaido, 070-8610, Japan
Tokyo Medical University Ibaraki Medical Center
Inashiki-gun, Ibaraki, 300-0395, Japan
Kaji Dermatology Clinic
Nonoichi-shi, Ishikawa-ken, 921-8801, Japan
Iwate Medical University Uchimaru Medical Center
Morioka, Iwate, 020-8505, Japan
Takeoka Dermatology Clinic
Marugame-shi, Kagawa-ken, 763-0074, Japan
Nippon Medical School Musashikosugi Hospital
Kawasaki-shi, Kanagawa, 211-8533, Japan
University Hospital Kyoto Prefectural University of Medicine
Kyoto, Kyoto, 602-8566, Japan
Rakuwakai Otowa Hospital
Kyoto, Kyoto, 607-8062, Japan
Mochida Dermatology Clinic
Izumiotsu-shi, Osaka, 595-0025, Japan
Dokkyo Medical University Hospital
Shimotsuga-gun, Tochigi, 321-0293, Japan
Teikyo University Hospital
Itabashi-ku, Tokyo, 173-8606, Japan
Nihon University Itabashi Hospital
Itabashi-ku, Tokyo, 173-8610, Japan
Outpatient clinic Veselibas Centrs 4
Riga, 1003, Latvia
Outpatient clinic Veselibascentrs 4
Riga, LV-1013, Latvia
Smite Aija practice in dermatology and venerology
Talsi, 3201, Latvia
PreCare Trial and Recruitment
Born, 6121 XK, Netherlands
AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy
Gdansk, 80-280, Poland
Centrum Medyczne Angelius Provita
Katowice, 40-611, Poland
Centrum Zdrowia i Urody Maxxmed
Lublin, 20-080, Poland
Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Spzoo
Malbork, 82-200, Poland
Twoja przychodnia Ncm
Nowa Sól, 67-100, Poland
Twoja przychodnia Pcm
Poznan, 61-293, Poland
Twoja Przychodnia Scm
Szczecin, 71-500, Poland
Alergo-Med Specjalistyczna Przychodnia Lekarska Spzoo
Tarnów, 33-100, Poland
Royalderm Agnieszka Nawrocka
Warsaw, 02-962, Poland
Dermatologiczna Praktyka Lekarska Michal Torz Dermaceum Centrum Badan Klinicznych
Wroclaw, 50-450, Poland
Hospital Lusiadas Lisboa
Lisbon, 1500-458, Portugal
Hospital Cuf Descobertas
Lisbon, 1998-018, Portugal
Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano
Matosinhos Municipality, 4464-513, Portugal
Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio
Porto, 4099-001, Portugal
Clinical Research of Puerto Rico
San Juan, 00909, Puerto Rico
Fakultna Nemocnica s poliklinikou F D Roosevelta Banska Bystrica
Banská Bystrica, 975 17, Slovakia
Derma therapy, spol s ro
Bratislava, 851 01, Slovakia
Sanare spol sro
Svidník, 089 01, Slovakia
Kaderma Majtan, sro
Topoľčany, 955 01, Slovakia
Fakultna nemocnica Trnava
Trnava, 917 75, Slovakia
Korea University Ansan Hospital
Ansansi, Gyeonggido, 15355, South Korea
The Catholic University of Korea Incheon St Marys Hospital
Incheon, 21431, South Korea
Seoul National University Hospital
Seoul, 03080, South Korea
National Medical Center
Seoul, 04564, South Korea
Asan Medical Center
Seoul, 05505, South Korea
Korea University Guro Hospital
Seoul, 08308, South Korea
Hospital Universitario Reina Sofia
Córdoba, Andalusia, 14004, Spain
Hospital Universitario Miguel Servet
Zaragoza, Aragon, 50009, Spain
Hospital Universitario de Gran Canaria Doctor Negrin
Las Palmas de Gran Canaria, Canary Islands, 35010, Spain
Hospital Universitari Germans Trias i Pujol
Badalona, Catalonia, 08916, Spain
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Catalonia, 08907, Spain
Hospital Clinico Universitario de Santiago
Pontevedra, Galicia, 36001, Spain
Hospital Universitario Quironsalud Madrid
Pozuelo de Alarcón, Madrid, 28223, Spain
Hospital Universitari i Politecnic La Fe
Valencia, Valencia, 46026, Spain
Hospital Universitario de La Princesa
Madrid, 28006, Spain
Hospital Universitario Infanta Leonor
Madrid, 28031, Spain
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 83301, Taiwan
National Cheng Kung University Hospital
Tainan, 70403, Taiwan
National Taiwan University Hospital
Taipei, 10002, Taiwan
Mackay Memorial Hospital Taipei Branch
Taipei, 10449, Taiwan
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
Linkou Chang Gung Memorial Hospital
Taoyuan District, 33305, Taiwan
Related Publications (2)
Guttman-Yassky E, Simpson E, Bissonnette R, Eichenfield LF, Kabashima K, Luna PC, Hercogova JT, Spelman L, Worm M, Esfandiari E, Arai T, Mano H, Charuworn P, Wang A, Kricorian G. ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis. Immunotherapy. 2025 Feb;17(2):83-94. doi: 10.1080/1750743X.2025.2464528. Epub 2025 Feb 26.
PMID: 40012373BACKGROUNDGuttman-Yassky E, Kabashima K, Worm M, Luna PC, Hong HC, Chovatiya R, Bernstein JA, Kern JS, Ehst BD, Magnolo N, Herranz-Pinto P, Stein Gold L, Sofen H, Pink AE, Esfandiari E, Arai T, Yang Y, Shi R, Barragan C, Kricorian G, Schwartz-Sagi L, Bissonnette R. Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials. Lancet. 2026 Jan 3;407(10523):53-66. doi: 10.1016/S0140-6736(25)01865-3. Epub 2025 Nov 25.
PMID: 41314226DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
MD
Amgen
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2022
First Posted
June 1, 2022
Study Start
May 31, 2022
Primary Completion
November 28, 2024
Study Completion
January 13, 2025
Last Updated
November 24, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data sharing requests relating to this study will be considered beginning 18 months after the study has ended and either 1) the product and indication have been granted marketing authorization in both the US and Europe or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this study.
- Access Criteria
- Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors. If not approved, a Data Sharing Independent Review Panel will arbitrate and make the final decision. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.
De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.